Search results
Results from the WOW.Com Content Network
The Cancer Research Institute (CRI) is a US non-profit organization funding cancer research and based in New York City. They were founded in 1953 to develop immunologically-based treatments for cancer, and despite their name are a funding body for research rather than a research institute themselves, working with other institutes and organizations.
Dr. Scholz has written and produced educational material on the subject of prostate cancer in various media including DVDs, blogs, newsletters and pamphlets. He is frequently an invited guest speaker in the community at prostate cancer conferences and prostate cancer support groups throughout the world.
Sarah Cannon Research Institute (SCRI) is a research organization focusing on therapies for patients which include drugs that are in development. With corporate headquarters in Nashville, Tennessee , United States, it conducts community-based clinical trials in oncology , cardiology , gastroenterology , and other therapeutic areas. [ 1 ]
The H 2-receptor antagonist cimetidine causes an increase in the plasma concentration of metformin by reducing clearance of metformin by the kidneys; [104] both metformin and cimetidine are cleared from the body by tubular secretion, and both, particularly the cationic (positively charged) form of cimetidine, may compete for the same transport ...
Cancer Research UK (CRUK) is the world's largest independent cancer research organisation. [2] [3] It is registered as a charity in the United Kingdom [1] and Isle of Man, and was formed on 4 February 2002 by the merger of The Cancer Research Campaign and the Imperial Cancer Research Fund. [4]
The National Cancer Research Institute (NCRI) is a UK-wide partnership between cancer research funders, which promotes collaboration in cancer research.Its member organizations work together to maximize the value and benefit of cancer research for the benefit of patients and the public.
Beginning in 2012, Friends of Cancer Research organized a series of conference panels and workshops to develop a new clinical trial structure for targeted squamous cell lung cancer drugs. [7] The resulting trial, Lung-MAP (Lung Cancer Master Protocol), is an "umbrella trial" that simultaneously tests several different experimental drugs ...
PCORI funds research studies that focus on patient-centered outcomes rather than only on CER alone. [9] [10] [2] Patient-centered outcomes research involves questions and outcomes that are "meaningful and important to patients and caregivers" [11] in order to help those individuals make informed decisions for their own care.